$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Analysis of whether isatuximab (Xacoyi) is a targeted drug and its mechanism of action and clinical application principles
2026-02-01 22:25:32
Check Details
Evaluation of the efficacy of capicitinib in tumor treatment and the experience of different patients
2026-02-01 22:25:32
Check Details
Differences in indications and efficacy and comparison of clinical applications between guselkumab (Tenoya) and cosentyx
2026-02-01 22:25:32
Check Details
Tenapanor hydrochloride (tenapanor) latest price reference in 2026 and analysis of drug purchase channels and cost explanations
2026-02-01 22:25:32
Check Details
Analysis of revumenib-REVUFORJ market pricing, reference price range and formal drug purchase channels
2026-02-01 22:25:32
Check Details
The efficacy of inavolisib combined with palbociclib and fulvestrant
2026-02-01 22:25:32
Check Details
Can Datopotamab be used with other medicines?
2026-02-01 22:25:32
Check Details
The drug definition and principle of action of Mavakatai/Mefanto
2026-02-01 22:25:32
Check Details
Drug contraindications and usage recommendations for tenofovir alafenamide fumarate tablets (Vemlidy)
2026-02-01 22:25:32
Check Details
Recommended medication duration and treatment schedule for Lemborexant
2026-02-01 22:25:32
Check Details
Study the contraindications for drug combination of entacapone/codan
2026-02-01 22:25:32
Check Details
Recommended clinical usage and treatment course of Inavolisib
2026-02-01 22:25:32
Check Details
1
2
...
2378
2379
2380
2381
2382
2383
2384
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma